Review

Flt-3 Ligand: A Potent Dendritic Cell Stimulator and Novel Antitumor

Volume 1, Issue 5   September/October 2002
Pages 486 - 489
http://dx.doi.org/10.4161/cbt.1.5.161
Authors: Jian Dong, Christopher M. McPherson and Peter J. Stambrook

View affiliations

Abstract:

Dendritic cell (DC) vaccination has generated intense interest as a potential cancer therapy. However, the rate limiting step has been the generation of DCs. Flt-3 ligand (FL) is a growth factor that was first discovered by its ability to stimulate the proliferation of hematopoietic progenitor cells of both lymphoid and myeloid origin. The remarkable activity of FL to induce large numbers of dendritic cells both in vivo and in vitro soon captured the interest of numerous researchers. In this review, we examine the structure and function of the FL, its antitumor activity in animal models, and its potential as a novel cancer treatment.

Key Words:

Flt3-L, Dendritic cells, Cell mediated immune response, Cancer therapy

Preview:



Advertisements